Ultrasensitive AMH Testing Provides New Insights into Midlife Ovarian Reserve

This development comes as women aged 35 to 55 face significant health challenges including declining fertility, perimenopausal symptoms, and difficulties in recognizing menopause. Ultrasensitive AMH testing offers new insights into ovarian reserve during this critical midlife transition period, potentially improving health management for women in this age group.

Originally published by gnews